Dr Trish Campbell is an infectious diseases modeller with a background in mathematics. During post-doctoral studies, Dr Campbell has developed models across a diverse range of diseases, including COVID-19, pertussis, respiratory syncytial virus (RSV), scabies and group A Streptococcus. Dr Campbell’s predominant research interests centre around using modelling to inform infectious disease control policies, particularly in disadvantaged populations and settings with limited information available for model development, with a current focus on scabies and soil-transmitted helminths. Since March 2020, Dr Campbell has been a member of a multidisciplinary team modelling the anticipated clinical requirements of potential COVID-19 outbreaks in Australia and Pacific Island countries, with modelling results and interpretation presented to health departments in each country to assist with their preparedness planning.
-
Key Achievements
-
Trish’s PhD research at The University of Melbourne into the drivers of pertussis spread and strategies to protect vulnerable infants was pivotal to the Australian Government’s decision to reinstate the 18 month pertussis booster on the National Immunisation Program. Internationally, this work has been translated into international infectious diseases policy through engagement with the World Health Organization. With a keen interest in training the next generation of researchers, Trish lectures Infectious Diseases Modelling at The University of Melbourne and supervises student projects across multi-disciplinary fields including infectious disease modelling, social epidemiology and modelling of mobility patterns.
Publications
Research Groups
-
McVernon Group
Jodie McVernon’s group uses established and emerging biostatistical, epidemiologic and modelling methods to address infectious diseases questions of public health relevance. We bring a suite of collaborators from animal health and ecology to provide a ‘One Health’ perspective on emerging human pathogens.
Lab Team
-
Professor and Director of Doherty Epidemiology
-
-
-
-
-
NHMRC early career fellow
-
-
Health Informatics Specialist
-
-
-
Tong Group
Steve’s group conducts clinical trials to optimise the treatment of infections due to methicillin-resistant Staphylococcus aureus and other bacterial pathogens. He also investigates the epidemiology and genomics of streptococcal infections, hepatitis B, influenza, and antimicrobial resistance in Australian Indigenous communities.
Lab Team
-
-
NHMRC early career fellow
-
-
Jake Lacey
Post-doctoral Researcher
-
Barbara Scher
Clinical Research Manager
-
-
Will Cuningham
Research Assistant
-
Aaron Weinman
PhD Student
